Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Coca-Cola (KO) Stock Rockets on Board Shake-Up and Bold Moves – What Investors Need to Know

Coca-Cola (KO) Stock Rockets on Board Shake-Up and Bold Moves – What Investors Need to Know

Sources: Recent Reuters and MarketBeat analyses, and The Coca-Cola Company’s own filings and press releases (cited above), provide the data and quotes used herein reuters.com reuters.com investors.coca-colacompany.com reuters.com ts2.tech. The market data reflect trading as of Oct. 17, 2025.
CRISPR Therapeutics Stock Explodes on Gene-Editing Breakthroughs – Analysts See 35% Upside

CRISPR Therapeutics Stock Explodes on Gene-Editing Breakthroughs – Analysts See 35% Upside

Clinical and Pipeline Progress CRISPR Therapeutics has reported a string of positive R&D updates in recent weeks. On October 10, 2025, CRSP presented preclinical results for CTX460, its SyNTase-based therapy for alpha-1 antitrypsin deficiency (AATD). The data – highlighted at
GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL’s logo at company headquarters. The Menlo Park biotech specializes in blood-based early cancer screening through its Galleri test news.samsung.com tradingview.com. GRAIL, Inc. is focused on early cancer detection – its mission is “to detect cancer early when it can
1 121 122 123 124 125 232
Go toTop